Loading
Latest filing published 04 Aug 2026 for Inhibitor Therapeutics, Inc.. Read the official filing
No signal scores available.
Samuel P. Sears Jr. discloses dealings in Inhibitor Therapeutics, Inc. to SEC (Form 4). The record holds 3 filings, for trades running from 1 April 2024 to 4 May 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 4 August 2026 came the latest disclosure, a share grant in Inhibitor Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 45 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations